Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage

Stroke

Volumn 39, Issue 1, 2008, Pages 185-190

  Ansar, Saema ^a   Edvinsson, Lars ^b  

^a LUND UNIVERSITY   (Sweden)

^b NONE

Author keywords

Cerebral arteries; Cerebral ischemia; Mitogen activated protein kinase (MAPK); Protein kinase C (PKC); Subarachnoid hemorrhage (SAH)

Indexed keywords

3 [1 (3 AMINOPROPYL) 3 INDOLYL] 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; BETA ACTIN; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; RECEPTOR; SB 386023 B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 3; RO 31-7549;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN CIRCULUS ARTERIOSUS; BRAIN ISCHEMIA; CISTERNA MAGNA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING; ANIMAL; CAPILLARY; DISEASE MODEL; DRUG ANTAGONISM; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN ISCHEMIA; CAPILLARIES; CEREBRAL ARTERIES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MALEIMIDES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-DELTA; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE;

EID: 38149037346     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.487827     Document Type: Article

References (38)

1. Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery. 1998;43:863-875; discussion 875-876.
2. Zervas NT. Vasospasm: an update. Clin Neurosurg. 1979;26:643-656.
3. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther. 1995;66:259-284.
4. Asano T. Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions. Crit Rev Neurosurg. 1999;9:303-318.
5. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105:23-56.
6. Shiokawa Y, Svendgaard NA. Cerebrovascular sensory innervation involved in the development of cerebral vasospasm following a subarachnoid hemorrhage. J Auton Nerv Syst. 1994;49(suppl):S167-170.
7. Nishizawa S, Obara K, Koide M, Nakayama K, Ohta S, Yokoyama T. Attenuation of canine cerebral vasospasm after subarachnoid hemorrhage by protein kinase C inhibitors despite augmented phosphorylation of myosin light chain. J Vasc Res. 2003;40:169-178.
8. Zhang JH, Aoki K, Zubkov AY, Tibbs RE. Role of MAPK in cerebral vasospasm role of MAPK in chronic cerebral vasospasm. Drug News Perspect. 2001;14:261-267.
9. 1B receptor in cerebral arteries in rats. J Neurosurg. 2003;99:115-120.
10. Hansen-Schwartz J, Hoel NL, Zhou M, Xu CB, Svendgaard NA, Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery. 2003;52:1188-1194, 1194-1195.
11. Beg SS, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. Protein kinase C inhibition prevents upregulation of vascular ET(b) and 5-HT(1b) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. J Cereb Blood Flow Metab. 2007;27:21-32.
12. Hansen-Schwartz J, Svensson CL, Xu CB, Edvinsson L. Protein kinase mediated upregulation of endothelin a, endothelin b and 5-hydroxytryptamine 1b/1d receptors during organ culture in rat basilar artery. Br J Pharmacol. 2002;137:118-126.
13. Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(b) and 5-HT(1b) receptor upregulation after subarachnoid hemorrhage in rat. J Cereb Blood Flow Metab. 2006;26:846-856.
14. Henriksson M, Xu CB, Edvinsson L. Importance of ERK1/2 in upregulation of endothelin type b receptors in cerebral arteries. Br J Pharmacol. 2004;142:1155-1161.
15. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998;74:49-139.
16. Zhu W, Zou Y, Aikawa R, Harada K, Kudoh S, Uozumi H, Hayashi D, Gu Y, Yamazaki T, Nagai R, Yazaki Y, Komuro I. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. Circulation. 1999;100:2100-2107.
17. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 1991;65:663-675.
18. Way KJ, Chou E, King GL. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci. 2000;21:181-187.
19. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J. 1993;291:329-343.
20. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258:607-614.
21. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery. 2003;52:165-175; discussion 175-176.
22. Beg SS, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. Protein kinase C inhibition prevents upregulation of vascular ET(b) and 5-HT(1b) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. J Cereb Blood Flow Metab. 2007;21:21-32.
23. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 1992;31:100-106; discussion 106-107.
24. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476.
25. McNeill AM, Kim N, Duckles SP, Krause DN, Kontos HA. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke. 1999;30:2186-2190.
26. Prunell GF, Mathiesen T, Svendgaard NA. Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery. 2004;54:426-436; discussion 436-437.
27. Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke. 1985;16:595-602.
28. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J. 2003;370:361-371.
29. Nishizawa S, Laher I. Signaling mechanisms in cerebral vasospasm. Trends Cardiovasc Med. 2005;15:24-34.
30. Bright R, Raval AP, Dembner JM, Perez-Pinzon MA, Steinberg GK, Yenari MA, Mochly-Rosen D. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci. 2004;24:6880-6888.
31. Chou WH, Messing RO. Protein kinase C isozymes in stroke. Trends Cardiovasc Med. 2005;15:47-51.
32. Bright R, Mochly-Rosen D. The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke. 2005;36:2781-2790.
33. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase C delta. Apoptosis. 2003;8:19-27.
34. Majumder PK, Mishra NC, Sun X, Bharti A, Kharbanda S, Saxena S, Kufe D. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ. 2001;12:465-470.
35. Irving EA, Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab. 2002;22:631-647.
36. Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24:916-925.
37. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. BMJ. 1989;298:636-642.
38. Zubkov AY, Nanda A, Zhang JH. Signal transduction pathways in cerebral vasospasm. Pathophysiology. 2003;9:47-61.